follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Catalent acquires marketing license for Redwood technology

By

Back to Top Comments Email Print

Latest News

advertisement

Catalent Pharma Solutions, in the Somerset section of Franklin, on Wednesday announced it has acquired an exclusive license to market Redwood Bioscience’s proprietary SmarTag technology for the development of advanced antibody-drug conjugates.

According to an announcement from Catalent, the deal will further improve the company’s capabilities to help customers develop more and better biologic treatments. Terms were not disclosed.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top